A link between p73 transcriptional activity and p73 degradation
- 15 March 2004
- journal article
- Published by Springer Nature in Oncogene
- Vol. 23 (22) , 4032-4036
- https://doi.org/10.1038/sj.onc.1207538
Abstract
The p53 family of proteins includes three members, p53, p63, and p73. The levels and stability of p53 are controlled in large part by MDM2, which can bind the p53 N-terminus and promote its degradation. Because the MDM2 gene is transcriptionally activated by p53, it forms part of an autoregulatory feedback loop that directly links the transcriptional activity of p53 with its degradation. In contrast, little is known about the mechanisms that control p63 or p73 stability. In the current study, p73 deletion or point mutants that lacked transactivation activity were stable compared to wild-type p73. A naturally occurring p73 variant (DeltaNp73) was also stable compared to wild-type p73. Finally, fusion of the VP16-transactivation domain to an inactive, stable p73 mutant restored transactivation function and rendered the mutant protein unstable. These results demonstrate that p73 transactivation activity is necessary for rapid p73 turnover, and suggest that one or more transcriptional targets of p73 may promote its degradation.Keywords
This publication has 24 references indexed in Scilit:
- Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 DegradationCell, 2003
- Hdmx and Mdm2 can repress transcription activation by p53 but not by p63Oncogene, 2001
- Regulation of p63 Function by Mdm2 and MdmXDNA and Cell Biology, 2001
- Identification of a Sequence Element from p53 That Signals for Mdm2-Targeted DegradationMolecular and Cellular Biology, 2000
- New p73 variants with altered C-terminal structures have varied transcriptional activitiesOncogene, 1999
- Mdm2 binds p73α without targeting degradationOncogene, 1999
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992